Clinical trial
Long-term Outcomes Following Drug Eluting Balloon Versus Thin Struts Drug Eluting Stents for Treating In-stent Restenosis: Propensity Score-matched Analysis(DEB-Dragon Registry).
NCT04415216 is registered in ClinicalTrials.gov with Medical University of Silesia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Outcomes Following Drug Eluting Balloon Versus Thin Struts Drug Eluting Stents for Treating In-stent Restenosis: Propensity Score-matched Analysis(DEB-Dragon Registry).
- Lead sponsor
- Medical University of Silesia
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 10, 2019
- Completion date
- March 1, 2020
- Enrollment
- 1,369 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
in stent restenosis